INDEX
A
Acridine orange .................................................. 32, 36, 37
Allele ..................................................................... 193, 194
Anticancer........................................................... 58, 60–65
Antigen presenting cells (APCs) ...................................... 4
Antimicrobial.............................................................15–26
B
Bacteriophage
ΦX174 ................................................................... 3–14
Gene E (LyE) ........................................................ 3–14
Bactofection................................................................. 3–14
Beads .................................................. 36, 38, 44, 91, 109,
162, 171–182
β-globin ................................................................ 193, 194
β1 integrin .......................................................... 23, 30, 33
Bioavailability ................................................... 57–67, 137
Bio-distribution..................................................... 98, 101,
106, 107
Brain Heart Infusion (BHI) .............................17, 20, 23,
24, 33, 34, 37
C
Carboxymethylcellulose (CMC) ........................ 175, 177,
179, 180
Cardiac .................................................................... 98, 112
Cationic .................................16, 17, 25, 43–54, 98, 114,
119, 125, 189
Cell-migration ................................................................. 73
Cell penetrating peptide (CPP)............................ 99–101,
103, 105, 106, 110, 113, 114, 119, 120
Cell shearing ......................................................... 161, 162
Chemotherapeutics .......................................... 57–67, 151
Chloroquine ....................................................... 16, 19, 22
Chromatography ..................................62, 126, 131, 134,
160, 180, 238
Clonal isolation ................................................... 197, 205,
210, 217, 225
Colloidal ....................................................................49, 54
Co-localization .............................................................. 105
Colon ..................................................................... 58, 157,
172, 182
CRISPR/Cas9.................................... 183–190, 193–210,
214–217, 221, 223–224
Cryopreservation...............................................20, 24, 34,
201, 215, 219–222
Curcumin................................................................ 58, 149
Cytotoxicity ...............................4, 12, 13, 58, 70, 72, 77,
114, 133, 213, 214
D
DAPI...........................................101, 107, 185, 188, 190
Differentiation............................................ 85, 86, 88, 89,
92–94, 194, 209
Dispersity ......................................................................... 49
Double-stranded break (DSB) ................... 183, 214, 215
Double-stranded RNA (dsRNA) .............................69–80
Drug delivery ............................................. 15, 54, 57, 70,
147–167, 171–182
E
E. coli
BL21(DE3) ............................................................. 6, 8
DH5α.................................................... 115, 196, 202,
215, 221, 223
DH10B .................................................. 17, 20, 33, 34
Embryonic stem cells .......................................... 85–95
Invasion ............................................ 3, 15–17, 19–26,
29–39, 124
YWT7-hly................................................................. 6, 8
YWTet-hly ................................................................ 6, 8
Electrophoretic mobility shift ................................ 46, 49,
53, 119
Electrospinning .................................................... 185, 186
Emulsification.............................................. 175, 177, 181
Enhanced green fluorescent protein
(EGFP)................................... 115, 117, 118, 120,
184, 185, 187–190
Enrichment..................................98, 103, 108, 109, 215,
217, 218, 224, 237
Enzyme protection assay ................................................ 48
Erythroid ....................................................................... 194
Ethidium bromide displacement.................................... 47
Exosomes............................................ 148–154, 156–159,
164–166
Expression ................................. 3–14, 17, 23, 29, 30, 43,
70, 72, 73, 78, 79, 89, 90, 124, 133, 137, 138,
163, 185, 188, 194, 196, 197, 199, 221, 224,
228, 233, 239
Kumaran Narayanan (ed.), Bio-Carrier Vectors: Methods and Protocols, Methods in Molecular Biology, vol. 2211,
https://doi.org/10.1007/978-1-0716-0943-9, © Springer Science+Business Media, LLC, part of Springer Nature 2021
241
A
Acridine orange .................................................. 32, 36, 37
Allele ..................................................................... 193, 194
Anticancer........................................................... 58, 60–65
Antigen presenting cells (APCs) ...................................... 4
Antimicrobial.............................................................15–26
B
Bacteriophage
ΦX174 ................................................................... 3–14
Gene E (LyE) ........................................................ 3–14
Bactofection................................................................. 3–14
Beads .................................................. 36, 38, 44, 91, 109,
162, 171–182
β-globin ................................................................ 193, 194
β1 integrin .......................................................... 23, 30, 33
Bioavailability ................................................... 57–67, 137
Bio-distribution..................................................... 98, 101,
106, 107
Brain Heart Infusion (BHI) .............................17, 20, 23,
24, 33, 34, 37
C
Carboxymethylcellulose (CMC) ........................ 175, 177,
179, 180
Cardiac .................................................................... 98, 112
Cationic .................................16, 17, 25, 43–54, 98, 114,
119, 125, 189
Cell-migration ................................................................. 73
Cell penetrating peptide (CPP)............................ 99–101,
103, 105, 106, 110, 113, 114, 119, 120
Cell shearing ......................................................... 161, 162
Chemotherapeutics .......................................... 57–67, 151
Chloroquine ....................................................... 16, 19, 22
Chromatography ..................................62, 126, 131, 134,
160, 180, 238
Clonal isolation ................................................... 197, 205,
210, 217, 225
Colloidal ....................................................................49, 54
Co-localization .............................................................. 105
Colon ..................................................................... 58, 157,
172, 182
CRISPR/Cas9.................................... 183–190, 193–210,
214–217, 221, 223–224
Cryopreservation...............................................20, 24, 34,
201, 215, 219–222
Curcumin................................................................ 58, 149
Cytotoxicity ...............................4, 12, 13, 58, 70, 72, 77,
114, 133, 213, 214
D
DAPI...........................................101, 107, 185, 188, 190
Differentiation............................................ 85, 86, 88, 89,
92–94, 194, 209
Dispersity ......................................................................... 49
Double-stranded break (DSB) ................... 183, 214, 215
Double-stranded RNA (dsRNA) .............................69–80
Drug delivery ............................................. 15, 54, 57, 70,
147–167, 171–182
E
E. coli
BL21(DE3) ............................................................. 6, 8
DH5α.................................................... 115, 196, 202,
215, 221, 223
DH10B .................................................. 17, 20, 33, 34
Embryonic stem cells .......................................... 85–95
Invasion ............................................ 3, 15–17, 19–26,
29–39, 124
YWT7-hly................................................................. 6, 8
YWTet-hly ................................................................ 6, 8
Electrophoretic mobility shift ................................ 46, 49,
53, 119
Electrospinning .................................................... 185, 186
Emulsification.............................................. 175, 177, 181
Enhanced green fluorescent protein
(EGFP)................................... 115, 117, 118, 120,
184, 185, 187–190
Enrichment..................................98, 103, 108, 109, 215,
217, 218, 224, 237
Enzyme protection assay ................................................ 48
Erythroid ....................................................................... 194
Ethidium bromide displacement.................................... 47
Exosomes............................................ 148–154, 156–159,
164–166
Expression ................................. 3–14, 17, 23, 29, 30, 43,
70, 72, 73, 78, 79, 89, 90, 124, 133, 137, 138,
163, 185, 188, 194, 196, 197, 199, 221, 224,
228, 233, 239
Kumaran Narayanan (ed.), Bio-Carrier Vectors: Methods and Protocols, Methods in Molecular Biology, vol. 2211,
https://doi.org/10.1007/978-1-0716-0943-9, © Springer Science+Business Media, LLC, part of Springer Nature 2021
241